BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30719695)

  • 1. Glucose-6-phosphatase Expression-Mediated [
    Kim MJ; Lee CH; Lee Y; Youn H; Kang KW; Kwon J; Alavi A; Carlin S; Cheon GJ; Chung JK
    Mol Imaging Biol; 2019 Oct; 21(5):917-925. PubMed ID: 30719695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin Promotes 2-Deoxy-2-[
    Wang Z; Kang F; Gao Y; Liu Y; Xu X; Ma X; Ma W; Yang W; Wang J
    Mol Imaging Biol; 2018 Jun; 20(3):388-397. PubMed ID: 29256045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.
    Kang F; Ma W; Ma X; Shao Y; Yang W; Chen X; Li L; Wang J
    J Nucl Med; 2014 Mar; 55(3):439-45. PubMed ID: 24504055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice.
    McLarty K; Moran MD; Scollard DA; Chan C; Sabha N; Mukherjee J; Guha A; McLaurin J; Nitz M; Houle S; Wilson AA; Reilly RM; Vasdev N
    Nucl Med Biol; 2011 Oct; 38(7):953-9. PubMed ID: 21982567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of PPAR-γ agonist on (18)F-FDG PET imaging for differentiating tumors and inflammation lesions.
    Cheong SJ; Lee CM; Kim EM; Lim ST; Sohn MH; Jeong HJ
    Nucl Med Biol; 2015 Feb; 42(2):85-91. PubMed ID: 25441255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of PPAR-gamma agonist on (18)F-FDG uptake in tumor and macrophages and tumor cells.
    Kim SL; Kim EM; Cheong SJ; Lee CM; Kim DW; Jeong HJ; Lim ST; Sohn MH; Yim CY
    Nucl Med Biol; 2009 May; 36(4):427-33. PubMed ID: 19423011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in 2-fluoro-2-deoxy-D-glucose incorporation, hexokinase activity and lactate production by breast cancer cells responding to treatment with the anti-HER-2 antibody trastuzumab.
    Cheyne RW; Trembleau L; McLaughlin A; Smith TA
    Nucl Med Biol; 2011 Apr; 38(3):339-46. PubMed ID: 21492782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of [18F]fluorodeoxyglucose accumulation in liver cancer.
    Izuishi K; Yamamoto Y; Mori H; Kameyama R; Fujihara S; Masaki T; Suzuki Y
    Oncol Rep; 2014 Feb; 31(2):701-6. PubMed ID: 24297035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.
    Christlieb SB; Strandholdt CN; Olsen BB; Mylam KJ; Larsen TS; Nielsen AL; Rohde M; Gerke O; Olsen KE; Møller MB; Kristensen BW; Abildgaard N; Alavi A; Høilund-Carlsen PF
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1824-36. PubMed ID: 27102266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Imaging of GLUT1 and GLUT5 in Breast Cancer: A Multitracer Positron Emission Tomography Imaging Study in Mice.
    Wuest M; Hamann I; Bouvet V; Glubrecht D; Marshall A; Trayner B; Soueidan OM; Krys D; Wagner M; Cheeseman C; West F; Wuest F
    Mol Pharmacol; 2018 Feb; 93(2):79-89. PubMed ID: 29142019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 2-amino-[3-¹¹C]isobutyric acid and 2-deoxy-2-[¹⁸F]fluoro-D-glucose in nude mice with xenografted tumors and acute inflammation.
    Tsuji AB; Kato K; Sugyo A; Okada M; Sudo H; Yoshida C; Wakizaka H; Zhang MR; Saga T
    Nucl Med Commun; 2012 Oct; 33(10):1058-64. PubMed ID: 22797465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting tumour response to anti-HER1 therapy using medical imaging: a literature review and in vitro study of [18F]-FDG incorporation by breast cancer cells responding to cetuximab.
    Smith TA; Cheyne RW
    Br J Biomed Sci; 2011; 68(3):158-66. PubMed ID: 21950209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
    Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
    Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive
    Henry KE; Dilling TR; Abdel-Atti D; Edwards KJ; Evans MJ; Lewis JS
    J Nucl Med; 2018 Jan; 59(1):51-57. PubMed ID: 28848040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexokinase and glucose-6-phosphatase activity in woodchuck model of hepatitis virus-induced hepatocellular carcinoma.
    Kuang Y; Schomisch SJ; Chandramouli V; Lee Z
    Comp Biochem Physiol C Toxicol Pharmacol; 2006 Jun; 143(2):225-31. PubMed ID: 16581304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II.
    Ong LC; Jin Y; Song IC; Yu S; Zhang K; Chow PK
    Acta Radiol; 2008 Dec; 49(10):1145-53. PubMed ID: 18979289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model.
    Liu RS; Chou TK; Chang CH; Wu CY; Chang CW; Chang TJ; Wang SJ; Lin WJ; Wang HE
    Nucl Med Biol; 2009 Apr; 36(3):305-12. PubMed ID: 19324276
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Chung SJ; Yoon HJ; Youn H; Kim MJ; Lee YS; Jeong JM; Chung JK; Kang KW; Xie L; Zhang MR; Cheon GJ
    J Nucl Med; 2018 May; 59(5):839-845. PubMed ID: 29326355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice.
    McLarty K; Fasih A; Scollard DA; Done SJ; Vines DC; Green DE; Costantini DL; Reilly RM
    J Nucl Med; 2009 Nov; 50(11):1848-56. PubMed ID: 19837760
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.